Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
about
Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cellsSustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasisTGF-β control of stem cell differentiation genesGEMMs as preclinical models for testing pancreatic cancer therapiesRegulation of TGF-β signal transduction by mono- and deubiquitylation of SmadsMouse models of pancreatic cancerPartners in crime: The role of tandem modules in gene transcriptionGenetically engineered mouse models of pancreatic adenocarcinomaTrim33 Binds and Silences a Class of Young Endogenous Retroviruses in the Mouse Testis; a Novel Component of the Arms Race between Retrotransposons and the Host GenomeA Poised Chromatin Platform for TGF-β Access to Master RegulatorsTranscription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemiaTGFβ signalling in contextActivated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathwaysDiversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmKRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinomaDynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation.Tumour suppressor TRIM33 targets nuclear β-catenin degradationTIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway.Brain expression of Cre recombinase driven by pancreas-specific promoters.Clinical characteristics of patients with anti-TIF1-γ antibodiesLoss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanismsTripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution.Isolation and culture of mouse primary pancreatic acinar cellsChallenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasisAnti-transcription intermediary factor 1-gamma autoantibody ELISA development and validationCommon pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders.Malignancy and idiopathic inflammatory myopathiesSMAD4 and its role in pancreatic cancer.Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance.Cells of origin of pancreatic neoplasms.Genome profiling of pancreatic adenocarcinoma.Acute sensitivity of the oral mucosa to oncogenic K-ras.
P2860
Q24303962-7FA24556-1783-4780-8096-41A62952904AQ24613046-AAD2033B-1F56-4CB5-A0C3-0556235DD986Q24630530-C4CFAC3D-E080-4B03-8517-D29DD1E04998Q26781848-4E5DA3C1-C941-4BF8-872B-9F85A4BAEF37Q26827667-DA9F5B3F-81D6-4919-B477-8E4156F8FAD7Q26860574-C1DB220C-E066-4E59-A38C-0CF4D287214AQ26995208-EB46CA5C-5315-44A5-B5BB-BCC17A8F6631Q27002973-E03E6BC6-3B64-4780-BDC3-808289EC9335Q27310010-5D47D923-A3E5-4758-B5D7-B12520DDF399Q27676403-351ACE4B-AA4D-4CAE-8D3E-5955E2D353CFQ28236628-AEBF2C85-591A-4D16-AC31-560693DA6F82Q28275410-71057822-28C8-4342-BEF6-28DA54E28632Q28478427-3F189DF3-63C7-4EAB-AB3E-D8226CD43A14Q33635144-FE291476-B552-4240-8B1C-02A08AFCA2ECQ33858490-4F8E2C0C-4BF3-47ED-8EE3-2DFB2CD12EB4Q34181413-14F07FF8-6DC4-466C-A5DD-86F57B38D42CQ34213815-95BB5666-97C1-4EC1-A044-A53FDAB54905Q34218656-A81E93EA-2B49-4DFA-8476-5A2ED0DE69EEQ35043217-870B2FB9-F9C1-45F0-B441-8F55757CE6D3Q35651935-EF619ABA-B7C0-4238-A7B7-D298D6000DD2Q36044646-F787B3EE-F982-44F4-B386-B142FD80A3A9Q36810383-8002E90B-073E-492C-91B3-81E81DE0CA3DQ36842501-C2FCFD2D-4654-4A1D-9495-E5DBA0C9C67BQ37161750-CDF03603-EB55-448B-82DE-D287798A19A5Q37289213-B8796F43-0356-423B-AD4B-27C91335127BQ37362619-CC40542A-15DB-4906-B782-B46B6EA795ECQ37375088-CCD61FF1-29B3-42AA-8F76-43667CD312FAQ37411831-CED5BD7D-DC9E-4854-B020-4C89E290B047Q37595996-F2DD0D1E-AAE2-4F8C-BE8A-76963BB5F31FQ37956169-1987C57A-F64D-4BA1-ACB1-3FD742EDE2F7Q38172212-9EE0E9A2-250E-4BB1-804A-6684EBEF9DDFQ38281261-0719BC02-468A-4030-9B91-10CD4277952DQ38407335-E51041C8-86AC-465A-B998-C5B7D082D065Q38596370-685A6F7C-91EE-4AD0-BA4D-04F2F6491C71Q38876622-2B233C90-822E-477B-82D5-42508E0A1460Q38982192-0451D347-1091-4E27-8200-9AE9BF7BCC2EQ39076794-81DD6600-3FE3-4397-B92E-D8752ACB3DFDQ39161835-BAF8B92F-A390-4EA7-9341-02A5316477C5Q39574924-4F86B36B-BE9A-441F-A34E-966892854986Q39868878-F470F7D7-5AF3-4A74-BCC3-A7E93F04D83A
P2860
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@ast
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@en
type
label
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@ast
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@en
prefLabel
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@ast
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@en
P2093
P2860
P50
P1433
P1476
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
@en
P2093
Bastien Kaniewski
Fabien Gay
Florian Lepinasse
Isabelle Treilleux
Juan L Iovanna
Julien C Marie
Kai-Ping Yan
Nabeel Bardeesy
Pierre Dubus
Ruth Rimokh
P2860
P304
P356
10.1371/JOURNAL.PGEN.1000575
P577
2009-07-24T00:00:00Z